EFPIA - NEWSLETTER

EFPIA Newsletter 22 January 2026

News

20 January 2026 EFPIA Statement on the EU–Mercosur Free Trade Agreement

While the agreement includes some progress for the innovative pharmaceutical sector, particularly through partial tariff...

20 January 2026 EFPIA statement following European Parliament plenary vote on the Critical Medicines Act

EFPIA acknowledges today’s vote in the European Parliament plenary on the Critical Medicines Act (CMA).

Blogs

20 January 2026 From readiness to reality: preparing Europe for the next phase of Alzheimer’s care (Guest blog)...

Europe has reached a turning point on Alzheimer’s disease, where scientific breakthroughs are no longer theoretical,...

Europe has a choice to make

Clinical trials matter. They give patients the earliest access to new medicines, up to 5-10 years before launch and deliver €1-1.5bn to health systems every year. Yet in just five years, Europe has lost 60,000 clinical trial places.

Europe is at a crossroads: bring clinical trials back or let the gap grow.

Learn more here.

Events

10 MAR 2026

2nd European Summit for Women Leaders in Life Sciences Brussels, Belgium

Get ready for C5’s 2nd Annual European Summit for Women Leaders in Life Sciences Law — two days of impactful discussions,...

Learn more →

03 JUN 2026

European Conference on Rare Diseases and Orphan Products (ECRD) 2026 Prague & Online

The next ECRD will be held on 3 & 4 June 2026 in Prague and will be titled “Rare Diseases in a Changing & Competitive...

Learn more →

What we are reading

Q&A Europe faces a pivotal moment in health innovation 22 January 2026 (POLITICO)

Alzheimer Europe launches discussion paper and guidelines for the ethical use of technology... 21 January 2026 (Alzheimer Europe)

Human medicines in 2025 15 January 2026 (EMA)

You can’t eliminate what you don’t measure: The data gap on HPV vaccination 11 December 2025 (Vaccines Today)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶